(Corrects paragraph 3 to say Pfizer is considering options with other drugmakers, not with P&G)
April 3 (Reuters) - Pfizer Inc is in talks with Procter & Gamble Co P&G.N for a sale of the U.S. drugmaker's consumer health business, CNBC reported on Tuesday, citing sources.
The companies were far apart on a price for the business, according to the report.
Pfizer is considering other options, including a joint venture with other drugmakers, CNBC said.
Pfizer and P&G could not be immediately reached for comment.
GlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion
Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila
